Effectiveness of Internet-based cognitive-behavioural therapy for obsessive-compulsive disorder (OCD-NET) and body dysmorphic disorder (BDD-NET) in the Swedish public health system using the RE-AIM implementation framework.
Body dysmorphic disorder
Clinical implementation
Internet-delivered cognitive behaviour therapy
Obsessive compulsive disorder
Journal
Internet interventions
ISSN: 2214-7829
Titre abrégé: Internet Interv
Pays: Netherlands
ID NLM: 101631612
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
28
11
2022
revised:
02
02
2023
accepted:
10
02
2023
entrez:
28
2
2023
pubmed:
1
3
2023
medline:
1
3
2023
Statut:
epublish
Résumé
Therapist-guided internet-delivered cognitive behaviour therapy (ICBT) is an efficacious treatment for obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD), but it is unclear if the results obtained in controlled trials can be reproduced in clinical settings. We evaluated the implementation of ICBT for OCD (OCD-NET) and BDD (BDD-NET) in the Swedish public health system. Consecutive referrals to an outpatient psychiatric clinic providing ICBT, with a primary diagnosis of OCD or BDD, were included in the study. Four hundred and thirty-four participants started OCD-NET and 163 started BDD-NET. The primary outcome measures were the Yale Brown Obsessive Compulsive Scale (Y-BOCS) and the Y-BOCS for BDD (BDD-YBOCS), respectively. Participants were assessed before treatment, weekly during treatment, and after treatment. The study used the RE-AIM implementation framework, and the elements of reach, effectiveness, adoption, and implementation for the evaluation. Intention to treat analysis of the OCD-NET sample ( Our results indicate that OCD-NET and BDD-NET are suitable treatments for implementation in a Swedish public health service.
Identifiants
pubmed: 36852382
doi: 10.1016/j.invent.2023.100608
pii: S2214-7829(23)00008-8
pmc: PMC9958485
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100608Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Prof. Mataix-Cols receives royalties for contributing articles to UpToDate, Wolters Kluwer Health, outside of the submitted work. Prof. Rück has received book royalties from Natur & Kultur, Studentlitteratur and Albert Bonniers Förlag and various speakers fees all unrelated to the submitted work. Dr Andersson receives royalties from Natur & Kultur for a self-help book on health anxiety Dr Flygare has received speaking fees from the Swedish OCD Association, Insight Events AB, and Kry International AB, as well as reimbursement for writing articles for Inside Practice Psychiatry, all outside the submitted work. Dr Enander has no competing interests to declare. Dr Radu has no competing interests to declare. Dr Ivanova has no competing interests to declare. MD Chen has no competing interests to declare.
Références
J Psychosom Res. 2011 Mar;70(3):286-93
pubmed: 21334500
World Psychiatry. 2016 Feb;15(1):80-1
pubmed: 26833615
BMJ Open. 2014 Sep 25;4(9):e005923
pubmed: 25256187
Psychol Assess. 2002 Dec;14(4):485-96
pubmed: 12501574
Behav Res Ther. 2014 Dec;63:99-106
pubmed: 25461784
Mol Psychiatry. 2017 Nov;22(11):1626-1632
pubmed: 27431293
Acta Psychiatr Scand. 2002 Aug;106(2):143-9
pubmed: 12121213
Internet Interv. 2023 Jan 24;31:100604
pubmed: 36756354
Behav Cogn Psychother. 2014 Sep;42(5):605-16
pubmed: 23823485
BMJ. 2016 Feb 02;352:i241
pubmed: 26837684
Psychol Med. 2021 Jan;51(1):83-89
pubmed: 31662124
Am J Psychiatry. 2006 Jul;163(7):1280-2
pubmed: 16816236
Psychopharmacol Bull. 1997;33(1):17-22
pubmed: 9133747
BMC Psychiatry. 2017 Feb 10;17(1):64
pubmed: 28183286
JAMA Netw Open. 2022 Mar 1;5(3):e221967
pubmed: 35285923
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Behav Res Ther. 1996 Aug;34(8):675-84
pubmed: 8870295
Depress Anxiety. 2010 May;27(5):470-5
pubmed: 20455248
BMJ Open. 2019 Jan 15;9(1):e024307
pubmed: 30647044
Patient Educ Couns. 2001 Aug;44(2):119-27
pubmed: 11479052
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Br J Clin Psychol. 2022 Nov;61(4):895-910
pubmed: 35315523
BMJ Open. 2019 Mar 23;9(3):e024693
pubmed: 30904854
Behav Cogn Psychother. 2014 Jul;42(4):497-501
pubmed: 23829940
Psychol Res Behav Manag. 2019 Dec 24;12:1167-1174
pubmed: 31920413
Depress Anxiety. 2020 Dec;37(12):1208-1220
pubmed: 33169490
Psychol Med. 2012 Oct;42(10):2193-203
pubmed: 22348650
Assessment. 2015 Oct;22(5):619-28
pubmed: 25268017
World Psychiatry. 2019 Feb;18(1):20-28
pubmed: 30600624
JAMA Psychiatry. 2015 Jul;72(7):659-67
pubmed: 25970252
Behav Cogn Psychother. 2019 Sep;47(5):559-572
pubmed: 30871650
J Clin Psychiatry. 2020 Jun 23;81(4):
pubmed: 32603559
Behav Ther. 2018 Jul;49(4):631-641
pubmed: 29937263
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
J Affect Disord. 2001 May;64(2-3):203-16
pubmed: 11313087
Body Image. 2016 Sep;18:168-86
pubmed: 27498379
Acta Psychiatr Scand. 1994 Jan;89(1):21-8
pubmed: 8140903
Am J Psychiatry. 2002 Feb;159(2):263-8
pubmed: 11823269
J Anxiety Disord. 2021 Aug;82:102444
pubmed: 34273871
Arch Gen Psychiatry. 1999 Feb;56(2):121-7
pubmed: 10025435
Psychol Med. 2014 Oct;44(13):2877-87
pubmed: 25066102
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
PLoS Med. 2017 Jun 27;14(6):e1002337
pubmed: 28654682
Eval Program Plann. 1979;2(3):197-207
pubmed: 10245370
Psychol Med. 2013 May;43(5):1109-17
pubmed: 23171833
J Nerv Ment Dis. 2011 Apr;199(4):268-71
pubmed: 21451352